MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Search

Quidel Corp

Fermé

12.65 -26.84

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.55

Max

17.29

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+57.23% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-408M

801M

Ouverture précédente

39.49

Clôture précédente

12.65

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 avr. 2026, 23:14 UTC

Résultats

Battery Maker CATL First-Quarter Net Rose on Strong Demand

15 avr. 2026, 23:14 UTC

Résultats

Battery Maker CATL First Quarter Net Rose On Strong Demand

15 avr. 2026, 17:13 UTC

Principaux Mouvements du Marché

Tesla Shares Rise on Completion of AI5 Chip Design Process

15 avr. 2026, 23:39 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

15 avr. 2026, 23:35 UTC

Market Talk
Principaux Événements d'Actualité

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

15 avr. 2026, 22:41 UTC

Résultats

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

15 avr. 2026, 22:38 UTC

Résultats

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

15 avr. 2026, 22:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 avr. 2026, 22:15 UTC

Market Talk

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

15 avr. 2026, 22:14 UTC

Résultats

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

15 avr. 2026, 22:12 UTC

Résultats

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

15 avr. 2026, 22:11 UTC

Résultats

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

15 avr. 2026, 22:11 UTC

Résultats

Lens Technology Swings to Loss in 1Q>300433.SZ

15 avr. 2026, 22:07 UTC

Résultats

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

15 avr. 2026, 21:34 UTC

Acquisitions, Fusions, Rachats

Skild AI Acquires Zebra Technologies' Robotics Automation Business

15 avr. 2026, 21:29 UTC

Actions en Tendance

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

15 avr. 2026, 20:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 avr. 2026, 20:30 UTC

Résultats

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

15 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 avr. 2026, 20:06 UTC

Market Talk

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

15 avr. 2026, 19:46 UTC

Résultats
Acquisitions, Fusions, Rachats

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

15 avr. 2026, 19:25 UTC

Market Talk

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

15 avr. 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

15 avr. 2026, 18:58 UTC

Market Talk
Principaux Événements d'Actualité

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

15 avr. 2026, 18:11 UTC

Acquisitions, Fusions, Rachats

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

15 avr. 2026, 17:45 UTC

Acquisitions, Fusions, Rachats

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

15 avr. 2026, 16:58 UTC

Résultats

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

15 avr. 2026, 16:52 UTC

Résultats

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

15 avr. 2026, 16:46 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

15 avr. 2026, 16:37 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

57.23% hausse

Prévisions sur 12 Mois

Moyen 27.5 USD  57.23%

Haut 38 USD

Bas 17 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat